Detail akcie MK Techno. -O- online

Business Summary: Mauna Kea Technologies SAS, also known as Mauna Kea Technologies SA, is a France-based company active in the healthcare business sector. It specializes in designing, developing, and selling medical imaging tools and systems. The Company’s products, used mainly in endoscopy, are intended for viewing and detecting deficiencies in the gastrointestinal and respiratory systems, primarily focusing on patients suffering from cancer. The main product offered by the Company is Cellvizio, a probe-based Confocal Laser Endomicroscopy (pCLE) which is a system providing physicians and researchers with high resolution cellular images of tissue in a real-time structure. The Company has marketing authorizations in Thailand, the United Kingdom, the USA, Brazil, Chile, South Korea, Poland, Russia and Saudi Arabia, among others.
Financial Summary: BRIEF: For the six months ended 30 June 2019, Mauna Kea Technologies SAS revenues increased 45% to EUR3.9M. Net loss increased 18% to EUR8.1M. Revenues reflect Miniprobe segment increase of 72% to EUR2.1M, Equipment segment increase of 36% to EUR1.3M, China segment increase from EUR506K to EUR1.4M, Americas segment increase of 40% to EUR1.9M. Higher net loss reflects Discounting expenses increase from EUR72K to EUR1.2M (expense).